The mediating role of C-reactive protein (CRP) and insulin resistance in the association of mid-childhood fat mass and airflow limitation at 15 years

G. Peralta (Barcelona, Spain), R. Granell (Bristol, United Kingdom), A. Bédard (Barcelona, Spain), L. Howe (Bristol, United Kingdom), A. Carsin (Barcelona, Spain), D. Jarvis (London, United Kingdom), J. Garcia-Aymerich (Barcelona, Spain)

Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Session: Mechanism or pathways of chronic lung diseases
Session type: E-poster session
Number: 2063
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Peralta (Barcelona, Spain), R. Granell (Bristol, United Kingdom), A. Bédard (Barcelona, Spain), L. Howe (Bristol, United Kingdom), A. Carsin (Barcelona, Spain), D. Jarvis (London, United Kingdom), J. Garcia-Aymerich (Barcelona, Spain). The mediating role of C-reactive protein (CRP) and insulin resistance in the association of mid-childhood fat mass and airflow limitation at 15 years. 2063

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
C-reactive protein in COPD and associations with smoking and body mass index
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007


C-reactive protein, obesity, atopy and asthma symptoms in middle-aged adults
Source: Eur Respir J 2008; 32: 77-84
Year: 2008



High-sensitive C-reactive protein is associated with reduced lung function in young adults
Source: Eur Respir J 2009; 33: 382-388
Year: 2009



Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006

High-sensitive C-reactive protein and lung function development between age 14 and age 20 years
Source: Annual Congress 2009 - New data on respiratory function - from experimental approaches to man
Year: 2009

Cardiorespiratory fitness, pulmonary function and C-reactive protein levels in adults with diabetes
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012

The relationship between weight loss, lung hyperinflation, adinopectin, ghrelin and leptin levels in COPD patients
Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function
Year: 2010


Is there a relationship between severity of COPD and C-reactive protein (CRP) levels?
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006

The polymorphisms of C-reactive protein gene modify the association between central obesity, asthma and lung function in Taiwan
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011

Genetic determinants of C-reactive protein in COPD
Source: Eur Respir J 2006; 28: 1156-1162
Year: 2006



Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity.
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Is the G223A polymorphism of the leptin receptor gene involved in the relationship between smoking behavior and body weight?
Source: Annual Congress 2005 - What's new in tobacco and lung disease
Year: 2005


Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients
Source: Eur Respir J 2009; 34: 776
Year: 2009


The relation between radiological extent and serum lipid parameters,total protein, albumin and body mass index in patients with pulmonary tuberculosis
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Elevated C-reactive protein is associated with reduced lung function and exercise capacity in normal subjects. Are we born inflammed?
Source: Eur Respir J 2006; 28: Suppl. 50, 331s
Year: 2006

Effects of steroid treatment on serum leptin level and haemostatic parameters in COPD patients with normal body mass index
Source: Eur Respir J 2006; 28: Suppl. 50, 30s
Year: 2006

Fat free mass is a major determinant of exercise tolerance in COPD patients
Source: Annual Congress 2010 - Rehabilitation: more than just exercise
Year: 2010

The impact of body mass index, central obesity and physical activity on lung function: results of the EpiHealth study
Source: ERJ Open Res, 6 (4) 00214-2020; 10.1183/23120541.00214-2020
Year: 2020



Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

Evaluation of association between OSA and metabolic syndrome, insulin resistance and Hs-CRP
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011